XENON PHARMACEUTICALS INC. (XENE) Operating cash flow 2016–2025
XENON PHARMACEUTICALS INC. (XENE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$279.1MFY2025 · since FY2016: -$19.6M → -$279.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$279.1M | -53.9% |
| FY2024 | -$181.4M | -20.0% |
| FY2023 | -$151.1M | -49.6% |
| FY2022 | -$101.0M | -45.4% |
| FY2021 | -$69.5M | -44.4% |
| FY2020 | -$48.1M | -920.9% |
| FY2019 | -$4.7M | +86.4% |
| FY2018 | -$34.7M | -20.9% |
| FY2017 | -$28.7M | -46.8% |
| FY2016 | -$19.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice